Pharma news
Pharma
Irish pharmaceutical company Amarin has petitioned the Supreme Court to revive its patents on its heart medication Vascepa. 18 February 2021
Pharma
Gilead Sciences and Bristol-Myers Squibb have said that a suit alleging they were involved in a long-running scheme to block generic competition and keep HIV medication prices artificially high is “legally defective”. 16 February 2021
Americas
The US Court of Appeals for the Federal Circuit has invalidated two Amgen antibody patents, finding that their functional claims were too broad. 16 February 2021
Americas
Cannabidiol retailer cbdMD is suing rival Majik Medicine over the latter’s use of the ‘CBD MD’ trademark, claiming it is confusing consumers. 15 February 2021
Pharma
Chances are, if you manage a life sciences portfolio, you had to rethink your monetization strategy last year. 15 February 2021
Pharma
Celgene has filed a lawsuit against Indian drugs manufacturer Dr Reddy’s Laboratories to halt its plan to produce and market generic versions of Pomalyst—Celgene’s multiple myeloma treatment. 11 February 2021
Pharma
China has introduced new measures to enforce a patent linkage system and proposed draft rules on how a patent owner can challenge the approval of a drug. 11 February 2021
Pharma
The US Court of Appeals for the Federal Circuit has agreed to reconsider its precedential ruling against Teva Pharmaceuticals for producing a generic hypertension and heart failure treatment, according to a Bloomberg Law report. 10 February 2021
Pharma
Jazz Pharmaceuticals has acquired UK medicinal cannabis company GW Pharmaceuticals in a takeover worth $7.2 billion. 4 February 2021
Pharma
Chinese drug maker Qilu’s proposed generic version of a cancer treatment infringes three patents, according to a lawsuit filed by Boehringer Ingelheim. 4 February 2021